ATE37712T1 - -2-(2-hydroxy-4-(substituierte)phenyl) piperidine. - Google Patents
-2-(2-hydroxy-4-(substituierte)phenyl) piperidine.Info
- Publication number
- ATE37712T1 ATE37712T1 AT84301635T AT84301635T ATE37712T1 AT E37712 T1 ATE37712 T1 AT E37712T1 AT 84301635 T AT84301635 T AT 84301635T AT 84301635 T AT84301635 T AT 84301635T AT E37712 T1 ATE37712 T1 AT E37712T1
- Authority
- AT
- Austria
- Prior art keywords
- phenyl
- alk2
- alk1
- piperidines
- hydroxy
- Prior art date
Links
- 150000003053 piperidines Chemical class 0.000 title 1
- 101100490437 Mus musculus Acvrl1 gene Proteins 0.000 abstract 3
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 125000002947 alkylene group Chemical group 0.000 abstract 2
- -1 2-[2-Hydroxy-4-(substituted)phenyl]piperidines Chemical class 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/474,957 US4529732A (en) | 1983-03-14 | 1983-03-14 | 2-[2-Hydroxy-4-(substituted)phenyl]piperidines |
EP84301635A EP0119087B1 (en) | 1983-03-14 | 1984-03-12 | 2-(2-hydroxy-4-(substituted) phenyl) piperidines |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE37712T1 true ATE37712T1 (de) | 1988-10-15 |
Family
ID=23885667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT84301635T ATE37712T1 (de) | 1983-03-14 | 1984-03-12 | -2-(2-hydroxy-4-(substituierte)phenyl) piperidine. |
Country Status (8)
Country | Link |
---|---|
US (1) | US4529732A (en, 2012) |
EP (1) | EP0119087B1 (en, 2012) |
JP (1) | JPS59176255A (en, 2012) |
AT (1) | ATE37712T1 (en, 2012) |
DE (1) | DE3474445D1 (en, 2012) |
DK (1) | DK113984A (en, 2012) |
GR (1) | GR81837B (en, 2012) |
IE (1) | IE57030B1 (en, 2012) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5342846A (en) * | 1990-12-05 | 1994-08-30 | Synphar Laboratories, Inc. | 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and 7-(substituted triazolyl pyrrolidin-1-yl) 4-oxoquinoline-3-carboxylic acid derivatives useful as antibacterial agents |
FR2793246B1 (fr) * | 1999-05-03 | 2001-06-29 | Adir | Nouveaux derives de 1-aza-2-alkyl-6-aryl-cycloalcanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
JP2005536554A (ja) * | 2002-08-23 | 2005-12-02 | ユニバーシティ オブ コネチカット | 新規なビフェニル及びビフェニル様カンナビノイド |
WO2007127711A2 (en) * | 2006-04-24 | 2007-11-08 | Allergan, Inc. | Abnormal cannabidiols as agents for lowering intraocular pressure |
US7618966B2 (en) | 2006-04-24 | 2009-11-17 | Allergan, Inc. | Abnormal Cannabidiols as agents for lowering intraocular pressure |
US7612101B2 (en) | 2006-04-24 | 2009-11-03 | Allergan, Inc. | Abnormal cannabidiols as agents for lowering intraocular pressure |
US7718830B2 (en) | 2006-04-24 | 2010-05-18 | Allergan, Inc. | Abnormal cannabidiols as agents for lowering intraocular pressure |
JP2025522912A (ja) * | 2022-07-06 | 2025-07-17 | ヴィヴィディオン セラピューティクス, インコーポレイテッド | Wrnヘリカーゼ阻害剤を含む医薬組成物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2498431A (en) * | 1945-06-13 | 1950-02-21 | Hoffmann La Roche | 2-and 4-homocyclyl substituted piperidines |
US3067204A (en) * | 1959-09-16 | 1962-12-04 | Smith Kline French Lab | 2, 2-dimethyl-6-phenylpiperidine derivatives |
FR1288025A (fr) * | 1960-02-08 | 1962-03-24 | Boehringer & Soehne Gmbh | Procédé de préparation de nouvelles piperidones-(4) substituées en position 1, 2, 6 ou de leurs sels |
US4147872A (en) * | 1977-09-13 | 1979-04-03 | Pfizer Inc. | 3-[2-Hydroxy-4-(substituted)-phenyl]azacycloalkanes and derivatives thereof as analgesic agents and intermediates therefor |
US4306097A (en) * | 1977-09-13 | 1981-12-15 | Pfizer Inc. | 3-[2-Hydroxy-4-(substituted)phenyl]-cycloalkanol analgesic agents |
US4216218A (en) * | 1979-02-23 | 1980-08-05 | American Hoechst Corporation | Antidepressant and analgesic 4-aryloxy- and 4-arylthio-3-phenylpiperidines |
-
1983
- 1983-03-14 US US06/474,957 patent/US4529732A/en not_active Expired - Fee Related
-
1984
- 1984-02-28 DK DK113984A patent/DK113984A/da not_active Application Discontinuation
- 1984-03-09 GR GR74041A patent/GR81837B/el unknown
- 1984-03-12 EP EP84301635A patent/EP0119087B1/en not_active Expired
- 1984-03-12 AT AT84301635T patent/ATE37712T1/de not_active IP Right Cessation
- 1984-03-12 DE DE8484301635T patent/DE3474445D1/de not_active Expired
- 1984-03-13 IE IE624/84A patent/IE57030B1/en not_active IP Right Cessation
- 1984-03-14 JP JP59048963A patent/JPS59176255A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
IE57030B1 (en) | 1992-03-25 |
US4529732A (en) | 1985-07-16 |
DK113984D0 (da) | 1984-02-28 |
EP0119087B1 (en) | 1988-10-05 |
GR81837B (en, 2012) | 1984-12-12 |
JPS59176255A (ja) | 1984-10-05 |
IE840624L (en) | 1984-09-14 |
EP0119087A1 (en) | 1984-09-19 |
JPS6237034B2 (en, 2012) | 1987-08-10 |
DK113984A (da) | 1984-09-15 |
DE3474445D1 (en) | 1988-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO933452D0 (no) | Et terapeutisk middel for parkinson's sykdom | |
ATE219077T1 (de) | Endothelin antagoniste | |
MX9306831A (es) | Nuevos compuestos heterociclicos. | |
NL180206B (nl) | Verbinding en geneesmiddel met analgetische werking. | |
GB2061272B (en) | Morpholine derivatives | |
NO932607D0 (no) | Piperidinderivater og anvendelse av disse | |
ATE37712T1 (de) | -2-(2-hydroxy-4-(substituierte)phenyl) piperidine. | |
MY106314A (en) | New tetrazole derivatives, process for their preparation and their use | |
EG16546A (en) | Therapeutic agents | |
SE8904127D0 (sv) | New biocyclic amino-substituted compounds | |
ES8707226A1 (es) | Procedimiento para preparar derivados de (dihidro-4, 5-1h-imidazolil-2)-2-didrido-2,3-indol | |
NO861630L (no) | Karbapenemderivater og fremgangsmaate til fremstilling derav. | |
NO941084L (no) | Neuroleptiske 2-substituerte perhydro-1-H-pyrido[1,2-aÅpyraziner | |
DE3666223D1 (en) | Anticonvulsant agents | |
NO944577L (no) | Hemming av effekten av amyloidogene proteiner | |
ES536218A0 (es) | Procedimiento para la obtencion de derivados de hidroxietilazoliloxima | |
ES468586A1 (es) | Procedimiento para la preparacion de nuevas piridobenzodia- zepinonas. | |
DK347387A (da) | Amidderivater | |
ATE29133T1 (de) | Troponon-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung. | |
NZ223664A (en) | 2,3-dihydro-3-phenyl-2-oxo-benzofuranylacetic acid amide derivatives and pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |